The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The FDA’s Medwatch has issued an alert to consumers and healthcare professionals regarding the expansion of an earlier recall of Ultilet insulin syringes and the additional recall of Closercare insulin syringes because of bacterial contamination with Paenibacillus. This bacteria presents a risk of local infection due to soft tissue injection with a contaminated syringe, and also a risk of introducing contaminating organisms into a previously sterile vial, thereby possibly degrading the insulin and leading to problems maintaining insulin levels.

Comments are closed.

Of Interest